COVID-19 – A Glimpse Into the Future
How can we see into the future? The simple answer is that we can’t. We are left only with guesses as to what may be. Some of these are educated and informed; others are wild speculation.
Read More

Britain to Try Mix-and-Match COVID-19 Vaccinations
MONDAY, Jan. 4, 2021 (HealthDay News) — If a second dose of the first COVID-19 vaccine is not available or the maker is not known, then another vaccine may be used.
Read More

Maintaining Safety With SARS-CoV-2 Vaccines
As we rapidly move from COVID-19 vaccination at large tertiary care health centers to vaccination at clinics, pharmacies and other ambulatory sites, attention must be given to an emerging challenge.
Read More

Antibody Status and Incidence of SARS-CoV-2 Infection in Healthcare Workers
The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.
Read More

Symptoms Persist in Many Discharged COVID-19 Patients
MONDAY, Jan. 11, 2021 (HealthDay News) — COVID-19 survivors frequently experience fatigue or muscle weakness, sleep difficulties, and anxiety or depression at six months after acute infection, according to a study published online Jan. 8 in The Lancet.
Read More

Baricitinib Plus Remdesivir for Hospitalized Adults With COVID-19
The results of this randomized trial show that, compared with remdesivir alone, remdesivir plus the JAK inhibitor baricitinib was associated with a shorter median time to recovery (7 days vs 8 days) in hospitalized patients with COVID-19.
Read More

Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults
Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administered earlier in the course of illness.
Read More